Zdrowie i gospodarka · 29/05/2014

FDA Expands Authority to Detain Adulterated or Misbranded Drugs

The Food and Drug Administration (FDA) is implementing its authority to administratively detain drugs intended for human or animal use, aiming to protect the public by preventing distribution of potentially adulterated or misbranded drugs. This new power is authorized by the Food and Drug Administration Safety and Innovation Act (FDASIA) and allows the FDA to take swift action to safeguard the integrity of the drug supply chain.